Eitaro Tanaka
About
In The Last Decade
Eitaro Tanaka
16 papers receiving 288 citations
Peers
Comparison fields: 5 of 85
- Molecular Biology 76
- Infectious Diseases 74
- Endocrinology, Diabetes and Metabolism 68
- Epidemiology 58
- Physiology 41
Countries citing papers authored by Eitaro Tanaka
This map shows the geographic impact of Eitaro Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eitaro Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eitaro Tanaka more than expected).
Fields of papers citing papers by Eitaro Tanaka
This network shows the impact of papers produced by Eitaro Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eitaro Tanaka. The network helps show where Eitaro Tanaka may publish in the future.
Co-authorship network of co-authors of Eitaro Tanaka
This figure shows the co-authorship network connecting the top 25 collaborators of Eitaro Tanaka. A scholar is included among the top collaborators of Eitaro Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eitaro Tanaka. Eitaro Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 26 | |
| 3 | 22 | |
| 4 | 11 | |
| 5 | Case of exogenous insulin-derived acanthosis nigricans caused by insulin injections. | 7 |
| 6 | 49 | |
| 7 | Long-term glycemic control in Japanese type 2 diabetes patients after switching treatment from twice-daily premixed insulin to once daily insulin glargine. | 2 |
| 8 | Efficacy of long-acting insulin analog insulin glargine at high dosage for basal-bolus insulin therapy in patients with type 2 diabetes. | 10 |
| 9 | Effectiveness of basal-supported oral therapy (BOT) using insulin glargine in patients with poorly controlled type 2 diabetes. | 7 |
| 10 | 24 | |
| 11 | 39 | |
| 12 | 11 | |
| 13 | 20 | |
| 14 | 59 | |
| 15 | Effect of the adrenergic beta 3-agonist, BRL37344, on heat production by brown adipocytes in obese and in older rats. | 3 |
| 16 | [A case of sinus-bronchi syndrome repeatedly detected Bordetella bronchiseptica from sputum]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.